A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells (original) (raw)

Nature volume 413, pages 531–534 (2001)Cite this article

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a prototype autoimmune disease mediated by type 1 helper T (TH1) cells and under the control of regulatory cells1,2,3. Here we report that a synthetic glycolipid ligand for CD1d-restricted natural killer T (NKT) cells expressing the semi-invariant T-cell receptor (Vα14+) is preventive against EAE. The ligand is an analogue of α-galactosylceramide (α-GC), a prototype NKT cell ligand, with a truncated sphingosine chain. α-GC causes NKT cells to produce both interferon (IFN)-γ and interleukin (IL)-4 (refs 4, 5). However, this new ligand can induce a predominant production of IL-4 by the NKT cells. A single injection of this glycolipid, but not of α-GC, consistently induced TH2 bias of autoimmune T cells by causing NKT cells to produce IL-4, leading to suppression of EAE. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand6 indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Nicholson, L. B. & Kuchroo, V. K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8, 837–842 (1996).
    Article CAS Google Scholar
  2. Kumar, V., Aziz, F., Sercarz, E. & Miller, A. Regulatory T cells specific for the same framework 3 region of the Vβ8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1725–1733 (1997).
    Article CAS PubMed Central Google Scholar
  3. Zhang, B-n., Yamamura, T., Kondo, T., Fujiwara, M. & Tabira, T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677–1687 (1997).
    Article CAS PubMed Central Google Scholar
  4. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 1626–1629 (1997).
    Article ADS CAS Google Scholar
  5. Spada, F. M., Koezuka, Y. & Porcelli, S. A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188, 1529–1534 (1998).
    Article CAS PubMed Central Google Scholar
  6. Brossay, L. et al. CD1d-mediated recognition of α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521–1528 (1998).
    Article CAS PubMed Central Google Scholar
  7. Bix, M. & Locksley, R. M. Natural T cells. Cells that co-express NKRP-1 and TCR. J. Immunol. 155, 1020–1022 (1995).
    CAS PubMed Google Scholar
  8. Bendelac, A., Rivera, M. N., Park, S. & Roark, J. H. Mouse CD1-specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 15, 535–562 (1997).
    Article CAS Google Scholar
  9. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. & Baxter, A. G. NKT cells: Facts, functions and fallacies. Immunol. Today 21, 573–583 (2000).
    Article CAS Google Scholar
  10. Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramer. J. Exp. Med. 192, 741–754 (2000).
    Article CAS PubMed Central Google Scholar
  11. Moody, D. B., Besra, G. S., Wilson, I. A. & Porcelli, S. A. The molecular basis of CD1-mediated presentation of lipid antigens. Immunol. Rev. 172, 285–296 (1999).
    Article CAS Google Scholar
  12. Mieza, M. A. et al. Selective reduction of Vα14+NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156, 4035–4040 (1996).
    CAS PubMed Google Scholar
  13. Kirsten, J. L. et al. α/β T cell receptor (TCR)+ CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187, 1047–1056 (1998).
    Article Google Scholar
  14. Sumida, T. et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182, 1163–1168 (1995).
    Article CAS Google Scholar
  15. Wilson, S. B. et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391, 177–181 (1998).
    Article ADS CAS Google Scholar
  16. Illés, Zs. et al. Differential expression of natural killer T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164, 4375–4381 (2000).
    Article Google Scholar
  17. Pál, E. et al. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662–668 (2001).
    Article Google Scholar
  18. Sloan-Lancaster, J. & Allen, P. M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14, 1–27 (1996).
    Article CAS Google Scholar
  19. Kappos, L. et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. Nature Med. 6, 1176–1182 (2000).
    Article CAS Google Scholar
  20. Pedotti, R. et al. An unexpected version of horror autotoxicus: Anaphylactic shock to a self-peptide. Nature Immunol. 2, 216–222 (2001).
    Article CAS Google Scholar
  21. Morita, M. et al. Synthesis of α-, β-monoglycosylceramides and four diastereomers of an α-galactosylceramide. Bioorg. Med. Chem. Lett. 5, 699–704 (1995).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank M. Taniguchi for supplying TCR Jα281-/- mice. This work was supported by a Research on Brain Science grant from the Ministry of Health, Labor and Welfare in Japan.

Author information

Author notes

  1. Katsuichi Miyamoto and Sachiko Miyake: These authors contributed equally to this work

Authors and Affiliations

  1. Department of Immunology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, 187-8502, Tokyo, Japan
    Katsuichi Miyamoto, Sachiko Miyake & Takashi Yamamura

Authors

  1. Katsuichi Miyamoto
    You can also search for this author inPubMed Google Scholar
  2. Sachiko Miyake
    You can also search for this author inPubMed Google Scholar
  3. Takashi Yamamura
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toTakashi Yamamura.

Rights and permissions

About this article

Cite this article

Miyamoto, K., Miyake, S. & Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.Nature 413, 531–534 (2001). https://doi.org/10.1038/35097097

Download citation